Recurrent Melanoma [clinicaltrials_resource:136d8e28abb59d0038c52eb141823762]
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00003552]Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00003646]Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00003647]Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg [clinicaltrials:NCT00003789]Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma [clinicaltrials:NCT00003895]Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma [clinicaltrials:NCT00005949]SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated [clinicaltrials:NCT00006003]Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma [clinicaltrials:NCT00006243]flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer [clinicaltrials:NCT00019396]Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00019448]Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma [clinicaltrials:NCT00019682]Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma [clinicaltrials:NCT00019890]PS-341 in Treating Patients With Metastatic Malignant Melanoma [clinicaltrials:NCT00024011]Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma [clinicaltrials:NCT00026143]Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma [clinicaltrials:NCT00026221]Decitabine in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00030615]BMS-247550 in Treating Patients With Stage IV Melanoma [clinicaltrials:NCT00036764]Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer [clinicaltrials:NCT00039091]Tipifarnib in Treating Patients With Metastatic Malignant Melanoma [clinicaltrials:NCT00060125]clinicaltrials:NCT00060333Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma [clinicaltrials:NCT00072163]clinicaltrials:NCT00072189Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers [clinicaltrials:NCT00074308]clinicaltrials:NCT00085189clinicaltrials:NCT00085306Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00087373]Tanespimycin in Treating Patients With Stage III-IV Melanoma [clinicaltrials:NCT00087386]Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors [clinicaltrials:NCT00089362]Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas [clinicaltrials:NCT00101270]clinicaltrials:NCT00110019Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors [clinicaltrials:NCT00112476]clinicaltrials:NCT00121225Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery [clinicaltrials:NCT00217542]clinicaltrials:NCT00243061Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery [clinicaltrials:NCT00255762]clinicaltrials:NCT00281957Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00288041]Vaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00303836]Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma [clinicaltrials:NCT00349206]clinicaltrials:NCT00387751
condition [clinicaltrials_vocabulary:condition]
Recurrent Melanoma [clinicaltrials_resource:136d8e28abb59d0038c52eb141823762]
Bio2RDF identifier
136d8e28abb59d0038c52eb141823762
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:136d8e28abb59d0038c52eb141823762
identifier
clinicaltrials_resource:136d8e28abb59d0038c52eb141823762
title
Recurrent Melanoma
@en
label
Recurrent Melanoma [clinicaltrials_resource:136d8e28abb59d0038c52eb141823762]
@en